Akari Therapeutics (AKTX) EV to EBIT (2014 - 2026)
Akari Therapeutics (AKTX) EV to EBIT (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EV to EBIT |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 232,854.65 |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -41,251.84 |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 604.41 |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 25.48 |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | 10,112.54 |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 15.49 |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 43.12 |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 49.30 |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -84.03 |
| 10 | Moderna | 28.64 Bn | 23.43 Bn | -566.00 Mn | -6.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 17, 2026 | -44,310.52 |
| Jul 16, 2026 | -46,685.01 |
| Jul 15, 2026 | -48,576.56 |
| Jul 14, 2026 | -54,009.73 |
| Jul 13, 2026 | -53,929.24 |
| Jul 10, 2026 | -55,861.03 |
| Jul 9, 2026 | -52,963.34 |
| Jul 8, 2026 | -57,189.14 |
| Jul 7, 2026 | -62,300.34 |
| Jul 6, 2026 | -43,867.81 |
| Jul 2, 2026 | -41,895.77 |
| Jul 1, 2026 | -41,251.84 |
| Jun 30, 2026 | -41,211.60 |
| Jun 29, 2026 | -38,998.08 |
| Jun 26, 2026 | -43,183.63 |
| Jun 25, 2026 | -38,313.91 |
| Jun 24, 2026 | -43,304.37 |
| Jun 23, 2026 | -47,449.68 |
| Jun 22, 2026 | -45,195.92 |
| Jun 18, 2026 | -44,028.79 |